GlaxoSmithKline PLC Total Voting Rights (6787E)
02 Marzo 2020 - 12:00PM
UK Regulatory
TIDMGSK
RNS Number : 6787E
GlaxoSmithKline PLC
02 March 2020
GlaxoSmithKline plc
Total Voting Rights and Capital
In conformity with the Financial Conduct Authority's Disclosure
Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the
'Company') hereby notifies the market of the following:
The Company's issued share capital as at 28 February 2020
consisted of 5,384,724,777 shares of 25 pence each ('Ordinary
Shares'), of which 367,705,950 Ordinary Shares were held in
Treasury.
Therefore, the total number of voting rights in the Company is
5,017,018,827. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
V A Whyte
Company Secretary
2 March 2020
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVRUPUCCWUPUGUP
(END) Dow Jones Newswires
March 02, 2020 06:00 ET (11:00 GMT)
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024